Fertility and contraception in women with cancer treatment undergoing chemotherapy
Fertilidad y anticoncepción en mujeres con cáncer en tratamiento quimioterápico
Fertilidade e contracepção em mulheres com câncer em tratamento quimioterápico
Stephanie da Silva; Renata Boer; Lóris Aparecida Prado da Cruz; Thais de Oliveira Gozzo
Abstract
Objective: to identify in women of reproductive age, with cancer and during chemotherapy treatment, the guidelines on fertility preservation and reproductive planning and to know the information provided by the health team.
Methods: descriptive study, conducted with premenopausal women diagnosed with cancer and undergoing chemotherapy. Data collection was performed with the support of an instrument with sociodemographic information about cancer and its treatments, information regarding the preservation of fertility and the use of contraceptive methods before and after cancer diagnosis. Data analysis was performed using descriptive statistics.
Results: the average age of the 49 participants was 38.2 years (SD=6.1) and 79.6% were being treated for breast cancer. Regarding the information received about the importance of reproductive planning, 77.6% of participants reported that they were oriented and 59.2% received such guidance from the medical team. However, regarding counseling on methods to maintain fertility, only 6.1% of participants were counseled.
Conclusion and Implications for practice: consideration should be given to the importance of expert counseling and the maintenance of active decision making by women about preserving their fertility.
Keywords
Resumen
Palabras clave
Resumo
Objetivo: identificar em mulheres em idade reprodutiva, com câncer e durante o tratamento quimioterápico, as orientações sobre preservação de fertilidade e planejamento reprodutivo e conhecer as informações fornecidas pela equipe de saúde.
Métodos: estudo descritivo, realizado com mulheres na pré-menopausa, com diagnóstico de câncer e em tratamento quimioterápico. A coleta de dados foi realizada com apoio de um instrumento com informações sociodemográficas, sobre o câncer e seus tratamentos, informações referentes a preservação de fertilidade e uso de métodos contraceptivos antes e após o diagnóstico do câncer. A análise dos dados foi feita por meio de estatística descritiva.
Resultados: a média de idade das 49 participantes foi de 38,2 anos (DP=6,1) e 79,6% estavam em tratamento devido ao câncer de mama. Quanto as informações recebidas sobre a importância do planejamento reprodutivo, 77,6% das participantes referiram que foram orientadas e 59,2% receberam tais orientações da equipe médica. Entretanto, em relação ao aconselhamento sobre métodos para manter a fertilidade, apenas, 6,1% das participantes foram orientadas.
Conclusão e Implicações para a prática: Deve-se considerar a relevância do aconselhamento especializado e a da manutenção de tomada de decisões ativas da mulher sobre a preservação de sua fertilidade.
Palavras-chave
References
1 American Cancer Society. Cancer facts and figures 2017. Atlanta: American Cancer Society, 2017 [citado 2019 nov 14]. Disponível em:
2 Jayasinghe YL, Wallace WHB, Anderson RA. Ovarian function, fertility and reproductive lifespan in cancer patients. Expert Rev Endocrinol Metab. 2018;13(3):125-36.
3 Madrigal JM, Atluri M, Radeke EK, Patel A. Looking through the lens of a family planner to prioritize reproductive health among women with cancer. J Oncol Pract. 2019;15(2):e141-52.
4 Johansen SL, Lerma K, Shaw KA. Contraceptive counseling in reproductive-age women treated for breast cancer at a tertiary care institution: a retrospective analysis. Contraception. 2017;96(4):248-53.
5 Ashizawa M, Kanda Y. Preservation of fertility in patients with hematological malignancies. Jpn J Clin Oncol. 2020;50(7):729-42.
6 Rashedi AS, Roo SF, Atamen LM, Edmonds ME, Silva AA, Scarella A et al. Survey of fertility preservation options available to patients with cancer around the globe. JCO Glob Oncol. 2020;6:JGO.2016.008144. PMid:32259160.
7 Logan S, Perz J, Ussher JM, Peate M, Anazodo A. A systematic review of patient oncofertility support needs in reproductive cancer patients aged 14 to 45 years of age. Psychooncology. 2018;27(2):401-9.
8 Ruddy KJ, Gelber SI, Tamimi RM, Ginsburg ES, Schapira L, Come SE et al. Prospective study of fertility concerns and preservation strategies in young women with breast cancer. J Clin Oncol. 2014 abr 10;32(11):1151-6.
9 Ussher JM, Perz J. Infertility-related distress following cancer for women and men: a mixed method study. Psychooncology. 2019;28(3):607-14.
10 Maslow BS, Morse CB, Schanne A, Loren A, Domchek SM, Gracia CR. Contraceptive use and the role of contraceptive counseling in reproductive-aged women with cancer. Contraception. 2014 jul;90(1):79-85.
11 Patel A, Sreedevi M, Malapati R, Sutaria R, Schoenhage MB, Patel AR et al. Reproductive health assessment for women with cancer: a pilot study. Am J Obstet Gynecol. 2009;201(2):191.e1-4.
12 Ballard-Barbash R, Taplin SH, Yankaskas BC, Ernster VL, Rosenberg RD, Carney PA et al. Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol. 1997 out;169(4):1001-8.
13 Kopeika J, Bhaduri M, Kugadas A, Reddy N, Shewbridge A, Mukherji D et al. Planned and unplanned pregnancies in breast cancer survivor. Breast. 2019;46:75-80.
14 Crafton SM, Lynch CD, Cohn DE, Eisenhauer EL. Reproductive counseling, contraception, and unplanned pregnancy in fertile women treated by gynecologic oncologists. Gynecol Oncol Rep. 2016;19:22-6.
15 Dominick SA, McLean MR, Whitcomb BW, Gorman JR, Mersereau JE, Bouknight JM et al. Contraceptive practices among female cancer survivors of reproductive age. Obstet Gynecol. 2015;126(3):498-507.
16 Castro-Sanchez A, Martinez-Cannon BA, Platas A, Mohar A, Fonseca A, Vega Y et al. Suboptimal use of effective contraceptive methods in young Mexican women with breast cancer. J Glob Oncol. 2018;4(4):1-7.
17 Shliakhtsitsava K, Suresh D, Hadnott T, Su IH. Best practices in counseling young female cancer survivors on reproductive health. Semin Reprod Med. 2017;35(4):378-89.
18 Crafton S, Nekkanti S, Lynch C, Cohn DE, Fowler JM, Copeland LJ et al. Documentation of pregnancy risk assessment and pregnancy among women presenting for gynaecologic oncology consultation. Int J Gynecol Cancer. 2016;26(1):35-42.
19 Dagan E, Modiano-Gattegno S, Birenbaum-Carmeli D. “My choice”: breast cancer patients recollect doctors fertility preservation recommendations. Support Care Cancer. 2017;25(8):2421-8.
20 Assi HI, Kakati RT, Attieh RM, Khoury J, Sukhon F, Berro J et al. Fertility in breast cancer survivors in the Middle East: a retrospective study. Breast. 2020;52:58-63.
21 Oktay K, Harvey BE, Partridge AH, Quinn GP, Reinecke J, Taylor HS et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2018;36(19):1994-2001.
22 Anazodo A, Laws P, Logan S, Saunders C, Travaglia J, Gerstl B et al. How cam we improve oncofertulity care for patients? A sistematic scoping review of current international practice and models of care. Hum Reprod Update. 2019;25(2):159-79.
23 Lindsay SF, Woodhams EJ, White KO, Drainoni ML, Johnson NL, Yinusa-Nyahkoon L. Understanding barriers to contraception screening and referral in female adolescents and young adults with cancer. J Adolesc Young Adult Oncol. 2020;9(1):63-71.
Submitted date:
03/24/2020
Accepted date:
06/23/2020
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email